Literature DB >> 15016013

rTMS reduces focal brain hyperperfusion in two patients with EPC.

A Graff-Guerrero1, J Gonzáles-Olvera, M Ruiz-García, U Avila-Ordoñez, V Vaugier, J C García-Reyna.   

Abstract

OBJECTIVE: This study was performed to evaluate the acute effect of a single repetitive transcranial magnetic stimulation (rTMS) session in a focal hyperperfusion epileptogenic region to induce a transitory decrease of epileptiform activity. CASE REPORT: Two epilepsia partialis continua (EPC)-diagnosed patients, received one session with 15 trains of rTMS (20 Hz; 2 s train, inter-train of 58 s). Before rTMS session, a brain ictal single photon emission computed tomography (SPECT) was performed to localize the focal frontal hyperperfusion region to establish the stimulation site. Immediately after the rTMS session another ictal SPECT was performed. Both patients showed a decrease of perfusion in the stimulated regions. For patient 1 epileptic seizures became intermittent until they stopped in the following 24 h. Patient 2 showed only a minimal improvement with a frequency decrease of epileptic spikes.
CONCLUSIONS: Our findings suggest that a single rTMS session reduces focal epileptogenic activity and could be an alternative approach for epileptic-resistant patients, but efficacy should be confirmed in a larger series.

Entities:  

Mesh:

Year:  2004        PMID: 15016013     DOI: 10.1046/j.1600-0404.2003.00222.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  15 in total

1.  Neuromodulation and Transcranial Mag Netic Stimulation (TMS): A 21st Century Paradigm for Therapeutics in Psychiatry.

Authors:  John P O'Reardon; Andrew D Peshek; Rocio Romero; Pilar Cristancho
Journal:  Psychiatry (Edgmont)       Date:  2006-01

Review 2.  Safety of noninvasive brain stimulation in children and adolescents.

Authors:  Chandramouli Krishnan; Luciana Santos; Mark D Peterson; Margaret Ehinger
Journal:  Brain Stimul       Date:  2014-10-28       Impact factor: 8.955

Review 3.  Therapeutic devices for epilepsy.

Authors:  Robert S Fisher
Journal:  Ann Neurol       Date:  2012-02       Impact factor: 10.422

Review 4.  Transcranial Magnetic Stimulation for the Treatment of Pediatric Neurological Disorders.

Authors:  Laura A Malone; Lisa R Sun
Journal:  Curr Treat Options Neurol       Date:  2019-11-13       Impact factor: 3.598

5.  Seizure Induced by Deep Transcranial Magnetic Stimulation in an Adolescent with Depression.

Authors:  Kathryn R Cullen; Suzanne Jasberg; Brent Nelson; Bonnie Klimes-Dougan; Kelvin O Lim; Paul E Croarkin
Journal:  J Child Adolesc Psychopharmacol       Date:  2016-07-22       Impact factor: 2.576

6.  Transcranial magnetic stimulation for refractory focal status epilepticus in the intensive care unit.

Authors:  Anli Liu; Trudy Pang; Susan Herman; Alvaro Pascual-Leone; Alexander Rotenberg
Journal:  Seizure       Date:  2013-07-19       Impact factor: 3.184

7.  Repetitive transcranial magnetic stimulation in the treatment of epilepsia partialis continua.

Authors:  Alexander Rotenberg; Erica Hyunji Bae; Masanori Takeoka; Jose M Tormos; Steven C Schachter; Alvaro Pascual-Leone
Journal:  Epilepsy Behav       Date:  2008-10-30       Impact factor: 2.937

8.  Seizure suppression by EEG-guided repetitive transcranial magnetic stimulation in the rat.

Authors:  Alexander Rotenberg; Paul Muller; Daniel Birnbaum; Michael Harrington; James J Riviello; Alvaro Pascual-Leone; Frances E Jensen
Journal:  Clin Neurophysiol       Date:  2008-11-01       Impact factor: 3.708

9.  Transient suppression of seizures by repetitive transcranial magnetic stimulation in a case of Rasmussen's encephalitis.

Authors:  Alexander Rotenberg; Dewi Depositario-Cabacar; Erica Hyunji Bae; Chellamani Harini; Alvaro Pascual-Leone; Masanori Takeoka
Journal:  Epilepsy Behav       Date:  2008-03-04       Impact factor: 2.937

10.  NON-INVASIVE BRAIN STIMULATION IN CHILDREN: APPLICATIONS AND FUTURE DIRECTIONS.

Authors:  Thilinie Rajapakse; Adam Kirton
Journal:  Transl Neurosci       Date:  2013-06       Impact factor: 1.757

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.